Lupin Limited (NSE:LUPIN) — Market Cap & Net Worth

$11.39 Billion USD · Rs1.05 Trillion INR · Rank #2022

Market Cap & Net Worth: Lupin Limited (LUPIN)

Lupin Limited (NSE:LUPIN) has a market capitalization of $11.39 Billion (Rs1.05 Trillion) as of May 2, 2026. Listed on the NSE stock exchange, this India-based company holds position #2022 globally and #80 in its home market, demonstrating a -0.12% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lupin Limited's stock price Rs2305.20 by its total outstanding shares 456967946 (456.97 Million). Analyse Lupin Limited cash conversion from operations to see how efficiently the company converts income to cash.

Lupin Limited Market Cap History: 2015 to 2026

Lupin Limited's market capitalization history from 2015 to 2026. Data shows growth from $8.63 Billion to $11.39 Billion (1.50% CAGR).

Index Memberships

Lupin Limited is a constituent of 13 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY PHARMA CNXPHARMA	$86.64 Billion	13.15%	#3 of 20
NIFTY GROWTH SECTORS 15 NI15	$263.61 Billion	4.32%	#8 of 15
NIFTY MIDCAP 100 NIFMDCP100	$519.63 Billion	2.19%	#10 of 100
NIFTY100 EQUAL WEIGHT NIFTY100EW	$1.79 Trillion	0.64%	#52 of 99
NIFTY 200 NIFTY200	$2.56 Trillion	0.44%	#74 of 200
NIFTY 500 NIFTY500	$3.11 Trillion	0.37%	#75 of 500
NIFTY HEALTHCARE NIFTYHEALTHCARE	$102.93 Billion	11.07%	#4 of 20
Nifty Low Volatility 50 NIFTYLVI	$997.46 Billion	1.14%	#25 of 48
NIFTY MIDCAP 150 NIFTYMIDCAP150	$695.80 Billion	1.64%	#11 of 150
NIFTY MIDCAP SELECT NIFTYMIDSELECT	$164.91 Billion	6.91%	#5 of 25
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.11 Trillion	1.03%	#15 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.36%	#74 of 750
NIFTY MIDCAP 50 NIMDCP50	$293.61 Billion	3.88%	#7 of 50

Weight: Lupin Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Lupin Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Lupin Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.05x

Lupin Limited's market cap is 0.05 times its annual revenue

Industry average: 1.04x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.32x

Lupin Limited's market cap is 0.32 times its annual earnings

Industry average: 8.30x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$7.02 Billion	$141.32 Billion	$22.61 Billion	0.05x	0.31x
2017	$4.20 Billion	$173.67 Billion	$25.57 Billion	0.02x	0.16x
2018	$4.04 Billion	$157.77 Billion	$2.51 Billion	0.03x	1.61x
2019	$3.67 Billion	$146.65 Billion	$6.07 Billion	0.03x	0.61x
2020	$4.73 Billion	$153.75 Billion	-$2.69 Billion	0.03x	N/A
2021	$4.63 Billion	$151.63 Billion	$12.17 Billion	0.03x	0.38x
2022	$3.59 Billion	$164.05 Billion	-$15.28 Billion	0.02x	N/A
2023	$6.51 Billion	$166.42 Billion	$4.30 Billion	0.04x	1.51x
2024	$11.64 Billion	$200.11 Billion	$19.14 Billion	0.06x	0.61x
2025	$10.43 Billion	$227.08 Billion	$32.82 Billion	0.05x	0.32x

Competitor Companies of LUPIN by Market Capitalization

Companies near Lupin Limited in the global market cap rankings as of May 2, 2026.

Key companies related to Lupin Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.09

Lupin Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Lupin Limited's market cap moved from $8.63 Billion to $ 11.39 Billion, with a yearly change of 1.50%.

Year	Market Cap	Change (%)
2026	Rs11.39 Billion	+9.28%
2025	Rs10.43 Billion	-10.45%
2024	Rs11.64 Billion	+78.84%
2023	Rs6.51 Billion	+81.09%
2022	Rs3.59 Billion	-22.35%
2021	Rs4.63 Billion	-2.13%
2020	Rs4.73 Billion	+28.79%
2019	Rs3.67 Billion	-8.99%
2018	Rs4.04 Billion	-4.02%
2017	Rs4.20 Billion	-40.08%
2016	Rs7.02 Billion	-18.71%
2015	Rs8.63 Billion	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Lupin Limited was reported to be:

Source	Market Cap
Yahoo Finance	$11.39 Billion USD
MoneyControl	$11.39 Billion USD
MarketWatch	$11.39 Billion USD
marketcap.company	$11.39 Billion USD
Reuters	$11.39 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic

Market Cap

$11.39 Billion

Rs1.05 Trillion INR

Market Cap Rank

#2022 Global

#80 in India

Share Price

Rs2305.20

Change (1 day)

-0.27%

52-Week Range

Rs1851.80 - Rs2357.30

All Time High

Rs2396.10